Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

3 Takeaways From 6th Circ. ERISA Disability Benefits Revival No Photo Available

Kellie Mejdrich

A recent Sixth Circuit ruling that handed a worker a new shot at long-term disability benefits gives a boost to plaintiffs battling ca... (more story)

W.Va. Amendment Marks Obstacle For Aid-In-Dying Movement No Photo Available

Gianna Ferrarin

A first-of-its-kind prohibition in West Virginia on medically assisted suicide represents a new form of opposition to a growing moveme... (more story)

Congress' Dash For Telehealth Extensions: 4 Things To Know No Photo Available

Mark Payne

With Republicans set to take control of Congress and the White House, lame-duck lawmakers on Capitol Hill are in a mad dash to pass le... (more story)